Paul-Henri Lambert

Direttore/Membro del Consiglio presso Hookipa Biotech AG

85 anni

Health Technology

Miscellaneous

Consumer Services

Posizioni attive di Paul-Henri Lambert

Società	Posizione	Inizio	Fine
Hookipa Biotech AG Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.	Direttore/Membro del Consiglio	-	-
Fondation Mérieux	Corporate Officer/Principal	14/11/2013	-
University of Geneva	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
HOOKIPA PHARMA INC.	Direttore/Membro del Consiglio	01/12/2011	25/04/2019

Distribuzione geografica

Posizioni

Director/Board Member	2
Corporate Officer/Principal	2

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
HOOKIPA PHARMA INC.	Health Technology

Aziende private	2
Hookipa Biotech AG Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.	Health Technology
Fondation Mérieux	Miscellaneous

Aziende private

Health Technology

Fondation Mérieux

Miscellaneous